Product complaint # (b)(4).Initial reporter occupation: lawyer.Dmf# - (b)(4), trade name gentamicin sulphate, active ingredient(s) gentamicin sulphate, dosage form - powder, strength 1.0g active in our cements.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Patient received a right attune knee to treat osteoarthritis.The patella was resurfaced and depuy cement x 2 was utilized.There were no indicated intra-operative complications.Patient received a right knee revision to address pain, discomfort, and tibial tray loosening at the cement to implant interface.The surgeon noted the removal of fibrous tissue.All components were revised.The patient was revised with depuy components and cement x 4.There were no indicated intra-operative complications.Doi: (b)(6) 2014; dor: (b)(6) 2021 right knee.
|
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.Device history lot: a device history record review was conducted as part of investigation in (b)(4).The record review and testing of retained samples did not reveal any non-conformances.
|